Media coverage about NantKwest (NASDAQ:NK) has been trending somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. NantKwest earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave media headlines about the biotechnology company an impact score of 45.5682203328805 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the news articles that may have impacted Accern Sentiment’s rankings:
- Here's Why NantKwest Inc. Tumbled 21.1% in July (finance.yahoo.com)
- Analysts said to Hold stock: NantKwest, Inc. (NK) – Street Observer (press release) (streetobserver.com)
- NantKwest, Inc. (NASDAQ:NK) Experiences Light Trading Volume – Modern Readers (modernreaders.com)
- NantKwest to Present at the 37th Annual Canaccord Genuity Growth Conference (finance.yahoo.com)
NantKwest (NASDAQ NK) traded up 3.62% during trading on Friday, reaching $5.87. 225,395 shares of the company’s stock traded hands. The firm’s 50 day moving average is $6.84 and its 200 day moving average is $4.88. The company’s market cap is $466.31 million. NantKwest has a 12 month low of $2.71 and a 12 month high of $9.60.
Several research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of NantKwest from a “hold” rating to a “buy” rating and set a $7.75 price target on the stock in a research report on Saturday, June 24th. BidaskClub lowered shares of NantKwest from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. Jefferies Group LLC set a $4.00 price target on shares of NantKwest and gave the stock a “hold” rating in a research report on Monday, May 8th. ValuEngine upgraded shares of NantKwest from a “strong sell” rating to a “sell” rating in a research report on Wednesday, June 14th. Finally, Citigroup Inc. cut shares of NantKwest from a “neutral” rating to a “sell” rating and set a $3.00 price objective on the stock. in a research report on Monday, May 15th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $10.79.
In other news, Director Steve Gorlin sold 40,000 shares of the stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of $7.78, for a total transaction of $311,200.00. Following the completion of the sale, the director now owns 409,725 shares of the company’s stock, valued at $3,187,660.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 70.19% of the stock is owned by corporate insiders.
NantKwest Company Profile
Receive News & Ratings for NantKwest Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantKwest Inc. and related companies with MarketBeat.com's FREE daily email newsletter.